Shanxi C&Y Pharmaceutical Group Co Ltd
ShanXi C&Y Pharmaceutical Group Co.,LTD. engages in the research, development, production, and sale of medicine and health food products. It provides anti-infective drugs, anti-allergic drugs, respiratory drugs, urinary system drugs, kidney disease drugs, children's drugs, cardiovascular and cerebrovascular drugs, anti-depressants, medicines, pharmaceutical raw materials, and intermediates, comme… Read more
Market Cap & Net Worth: Shanxi C&Y Pharmaceutical Group Co Ltd (300254)
Shanxi C&Y Pharmaceutical Group Co Ltd (SHE:300254) has a market capitalization of $411.53 Million (CN¥3.02 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #12243 globally and #3004 in its home market, demonstrating a -3.12% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shanxi C&Y Pharmaceutical Group Co Ltd's stock price CN¥11.79 by its total outstanding shares 256108563 (256.11 Million).
Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap History: 2015 to 2026
Shanxi C&Y Pharmaceutical Group Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.01 Billion to $411.53 Million (-6.98% CAGR).
Shanxi C&Y Pharmaceutical Group Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shanxi C&Y Pharmaceutical Group Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.36x
Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 0.36 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
7.24x
Shanxi C&Y Pharmaceutical Group Co Ltd's market cap is 7.24 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.01 Billion | $683.93 Million | $22.90 Million | 1.48x | 44.10x |
| 2016 | $665.30 Million | $746.08 Million | $30.15 Million | 0.89x | 22.07x |
| 2017 | $356.88 Million | $938.93 Million | $21.67 Million | 0.38x | 16.47x |
| 2018 | $225.60 Million | $1.14 Billion | $7.24 Million | 0.20x | 31.16x |
| 2019 | $283.08 Million | $1.13 Billion | $5.30 Million | 0.25x | 53.44x |
| 2020 | $240.50 Million | $848.07 Million | -$262.37 Million | 0.28x | N/A |
| 2021 | $303.33 Million | $930.37 Million | -$91.44 Million | 0.33x | N/A |
| 2022 | $236.31 Million | $829.00 Million | -$118.57 Million | 0.29x | N/A |
| 2023 | $336.14 Million | $799.31 Million | $25.20 Million | 0.42x | 13.34x |
| 2024 | $305.42 Million | $846.61 Million | $42.19 Million | 0.36x | 7.24x |
Competitor Companies of 300254 by Market Capitalization
Companies near Shanxi C&Y Pharmaceutical Group Co Ltd in the global market cap rankings as of March 18, 2026.
Key companies related to Shanxi C&Y Pharmaceutical Group Co Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shanxi C&Y Pharmaceutical Group Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Shanxi C&Y Pharmaceutical Group Co Ltd's market cap moved from $1.01 Billion to $ 411.53 Million, with a yearly change of -6.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥411.53 Million | +16.50% |
| 2025 | CN¥353.24 Million | +15.66% |
| 2024 | CN¥305.42 Million | -9.14% |
| 2023 | CN¥336.14 Million | +42.25% |
| 2022 | CN¥236.31 Million | -22.09% |
| 2021 | CN¥303.33 Million | +26.12% |
| 2020 | CN¥240.50 Million | -15.04% |
| 2019 | CN¥283.08 Million | +25.48% |
| 2018 | CN¥225.60 Million | -36.79% |
| 2017 | CN¥356.88 Million | -46.36% |
| 2016 | CN¥665.30 Million | -34.12% |
| 2015 | CN¥1.01 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shanxi C&Y Pharmaceutical Group Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $411.53 Million USD |
| MoneyControl | $411.53 Million USD |
| MarketWatch | $411.53 Million USD |
| marketcap.company | $411.53 Million USD |
| Reuters | $411.53 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.